Morgil Göksel Koç, Çok İsmet
Minister of Health, General Directorate of Public Health, Department of Consumer Safety and Public Health Laboratories, Toxicology Laboratory, Sıhhıye, Ankara, Türkiye.
Faculty of Pharmacy, Department of Toxicology, Gazi University, Ankara, Turkiye.
Toxicol Mech Methods. 2025 Feb;35(2):125-135. doi: 10.1080/15376516.2024.2390028. Epub 2024 Aug 13.
This study, aimed to determine and compare DNA damage in e-cigarette and HTP (IQOS) users by assessing DNA-adducts, which are biomarkers of various DNA alkylation and oxidation.
For the evaluation of DNA alkylation, N-Ethyladenine (N-EtA) and N-Methyladenine (N-MeA) adducts were used. DNA oxidation was assessed using, 8-hydroxy-2'-deoxyguanosine(8-OHdG). The urinary cotinine, N-MeA, N-EtA, and 8-OHdG concentrations of the cigarette smokers (n:39), e-cigarette users (n:28), IQOS users (n:20), passive smokers (n:32), and nonsmokers(n:41) who lived Ankara, Turkiye were determined using, liquid chromatography-tandem mass spectrometry (LC-MS/MS).
In light of the detected 8-OHdG levels, e-cigarette (3.19 ng/g creatinine) and IQOS (4.38 ng/g creatinine) users had higher oxidative DNA damage than healthy nonsmokers (2.51 ng/g creatinine). Alkylated DNA-adducts were identified in the urine of e-cigarette (N-MeA: 3.92 ng/g creatinine; N-EtA: 0.23 ng/g creatinine) and IQOS (N-MeA: 7.54 ng/g creatinine; N-EtA: 0.29 ng/g creatinine) users. In the generation of N-MeA adducts, a significant difference was found between IQOS users and e-cigarette users ( < 0.05). Also, DNA alkylation in flavored e-cigarette users (N-MeA: 4.51 ng/g creatinine; N-EtA: 0.27 ng/g creatinine) was higher than in non-flavored e-cigarette users (N-MeA: 2.27 ng/g creatinine; N-EtA: 0.06 ng/g creatinine). The highest cotinine levels were found in cigarette smokers (16.1316 ng/g creatinine). No significant difference was found when e-cigarette (1163.02 ng/g creatinine) and IQOS smokers were compared (1088.3 ng/g creatinine).
People who use e-cigarettes and IQOS may be at higher risk of genotoxicity than those who do not use and are not exposed to any tobacco products. Furthermore, the usage of flavoring additives in e-cigarettes contributed to additional genotoxic damage risks.
本研究旨在通过评估DNA加合物(各种DNA烷基化和氧化的生物标志物)来确定和比较电子烟和加热不燃烧烟草制品(IQOS)使用者的DNA损伤情况。
为评估DNA烷基化,使用了N-乙基腺嘌呤(N-EtA)和N-甲基腺嘌呤(N-MeA)加合物。使用8-羟基-2'-脱氧鸟苷(8-OHdG)评估DNA氧化。采用液相色谱-串联质谱法(LC-MS/MS)测定了居住在土耳其安卡拉的吸烟者(n = 39)、电子烟使用者(n = 28)、IQOS使用者(n = 20)、被动吸烟者(n = 32)和不吸烟者(n = 41)的尿可替宁、N-MeA、N-EtA和8-OHdG浓度。
根据检测到的8-OHdG水平,电子烟使用者(3.19 ng/g肌酐)和IQOS使用者(4.38 ng/g肌酐)的氧化性DNA损伤高于健康不吸烟者(2.51 ng/g肌酐)。在电子烟使用者(N-MeA:3.92 ng/g肌酐;N-EtA:0.23 ng/g肌酐)和IQOS使用者(N-MeA:7.54 ng/g肌酐;N-EtA:0.29 ng/g肌酐)的尿液中鉴定出烷基化DNA加合物。在N-MeA加合物的生成方面,IQOS使用者和电子烟使用者之间存在显著差异(P < 0.05)。此外,调味电子烟使用者中的DNA烷基化(N-MeA:4.51 ng/g肌酐;N-EtA:0.27 ng/g肌酐)高于非调味电子烟使用者(N-MeA:2.27 ng/g肌酐;N-EtA:0.06 ng/g肌酐)。吸烟者的可替宁水平最高(16.1316 ng/g肌酐)。比较电子烟使用者(1163.02 ng/g肌酐)和IQOS使用者(1088.3 ng/g肌酐)时未发现显著差异。
使用电子烟和IQOS的人可能比不使用且未接触任何烟草制品的人面临更高的遗传毒性风险。此外,电子烟中调味添加剂的使用增加了额外的遗传毒性损伤风险。